Jerry H Gurwitz
Overview
Explore the profile of Jerry H Gurwitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
295
Citations
7056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Cocoros N, Gurwitz J, Cziraky M, Granger C, Harkins T, Haynes K, et al.
Clin Trials
. 2023 Jun;
20(4):416-424.
PMID: 37322894
Background: There are unique opportunities related to the design and conduct of pragmatic trials embedded in health insurance plans, which have longitudinal data on member/patient demographics, dates of coverage, and...
13.
Rochon P, Stall N, Reppas-Rindlisbacher C, Gurwitz J
Eur Geriatr Med
. 2023 May;
14(4):635-637.
PMID: 37256474
No abstract available.
14.
Tisminetzky M, Gurwitz J, Tabada G, Reynolds K, Smith D, Sung S, et al.
Med Care
. 2023 Mar;
61(5):268-278.
PMID: 36920167
Background: The optimal approach to classifying multimorbidity burden in assessing treatment-associated outcomes using real-world data remains uncertain. We assessed whether 2 measurement approaches to characterize multimorbidity influenced observed associations of...
15.
Pham T, Patel P, Mbusa D, Kapoor A, Crawford S, Sadiq H, et al.
J Thromb Thrombolysis
. 2022 Dec;
55(2):346-354.
PMID: 36510110
Patient education of high-risk medications such as direct oral anticoagulants (DOACs) is limited in ambulatory care settings. Clinical pharmacists are uniquely equipped to educate patients about DOACS but seldom interact...
16.
Wang W, Lessard D, Kiefe C, Goldberg R, Parish D, Helm R, et al.
J Am Geriatr Soc
. 2022 Oct;
71(2):394-403.
PMID: 36273408
Background: In older patients with atrial fibrillation (AF), cognitive impairment and frailty are prevalent. It is unknown whether the risk and benefit of anticoagulation differ by cognitive function and frailty....
17.
Bamgbade B, McManus D, Briesacher B, Lessard D, Mehawej J, Gurwitz J, et al.
J Am Pharm Assoc (2003)
. 2022 Sep;
63(1):125-134.
PMID: 36171156
Background: As patient prices for many medications have risen steeply in the United States, patients may engage in cost-reducing behaviors (CRBs) such as asking for generic medications or purchasing medication...
18.
McCarthy L, Savage R, Dalton K, Mason R, Li J, Lawson A, et al.
Drugs Aging
. 2022 Sep;
39(10):829-840.
PMID: 36107399
Background And Objective: Prescribing cascades occur when a drug is prescribed to manage side effects of another drug, typically when a side effect is misinterpreted as a new condition. A...
19.
Rochon P, Petrovic M, Cherubini A, Onder G, OMahony D, Sternberg S, et al.
Lancet Healthy Longev
. 2022 Sep;
2(5):e290-e300.
PMID: 36098136
Polypharmacy is very common in older adults and increases the risk of inappropriate and unsafe prescribing for older adults. Older adults, particularly women (who make up the majority of this...
20.
Tisminetzky M, Gurwitz J, Tabada G, Reynolds K, Fortmann S, Garcia E, et al.
Am J Med
. 2022 Sep;
135(12):1468-1477.
PMID: 36058306
Background: Current clinical practice guidelines recommend routine kidney function and serum potassium testing within 30 days of initiating angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) therapy. However,...